|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16753388.4 (espacenet) (Federated) (European Patent Register), 20160818 | | Patent/reg. no. and date | DK/EP 3337800, 20190612 | | Publication date | 20180627 | | Priority no. and date | EP 15182043, 20150821 | | EP pub. no. and date |
EP 3337800 20180627 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | 1507080 | | Inventor | PLATZEK, Johannes, Grottkauer Str. 55
12621 Berlin, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61P 9/00 (2006.01) , C07D 471/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF (4S)- 4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXAMID OG DETS OPRENSNING TIL ANVENDELSE SOM FARMACEUTISK AKTIVT STOF | | Int. application no. | EP2016069558 | | Int. publication no. | WO2017032673 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
